These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1684702)

  • 41. The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortality.
    Johannes CB; McQuay LJ; Midkiff KD; Calingaert B; Andrews EB; Tennis P; Brown JS; Camargo CA; DiSantostefano RL; Rothman KJ; Stürmer T; Lanes S; Davis KJ
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):446-458. PubMed ID: 28000298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma.
    Beasley R; Pavord I; Papi A; Reddel HK; Harrison T; Marks GB; Hancox RJ; Weatherall M
    Eur Respir J; 2016 Mar; 47(3):981-4. PubMed ID: 26846834
    [No Abstract]   [Full Text] [Related]  

  • 43. Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
    Ortega VE; Peters SP
    Curr Opin Pharmacol; 2010 Jun; 10(3):246-53. PubMed ID: 20452285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma?
    Lancet; 1981 Jul; 2(8236):36-8. PubMed ID: 6113405
    [No Abstract]   [Full Text] [Related]  

  • 45. [Asthma control by utilizing the synergistic effect of inhaled steroids and long-acting beta 2 agonists].
    Ehlers M
    MMW Fortschr Med; 2004 Feb; 146(8):43. PubMed ID: 15346937
    [No Abstract]   [Full Text] [Related]  

  • 46. [Increasing mortality of asthma, overtreatment, undertreatment and wrong treatment].
    Haase H
    Ugeskr Laeger; 1991 Nov; 153(45):3160. PubMed ID: 1683500
    [No Abstract]   [Full Text] [Related]  

  • 47. Beta-agonists and death from asthma.
    Staudinger HW; Haas JF
    N Engl J Med; 1992 Jul; 327(5):355; author reply 356-7. PubMed ID: 1352378
    [No Abstract]   [Full Text] [Related]  

  • 48. Beta-agonists and death from asthma.
    Gottlieb DJ; Celli BR
    N Engl J Med; 1992 Jul; 327(5):355; author reply 356-7. PubMed ID: 1352377
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of inhaled long-acting beta-2 agonists in the management of asthma.
    Kelly HW; Harkins MS; Boushey H
    J Natl Med Assoc; 2006 Jan; 98(1):8-16. PubMed ID: 16532973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Beta 2 agonists in asthma therapy should be reevaluated--concerning the dosage].
    Larsson K
    Lakartidningen; 1991 Oct; 88(44):3643-5. PubMed ID: 1682539
    [No Abstract]   [Full Text] [Related]  

  • 51. (R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con].
    Ameredes BT; Calhoun WJ
    Am J Respir Crit Care Med; 2006 Nov; 174(9):965-9; discussion 972-4. PubMed ID: 17060667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New developments in bronchodilator therapy.
    Nelson HS
    Curr Opin Pulm Med; 1996 Jan; 2(1):35-9. PubMed ID: 9363113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perspectives in beta 2-agonist therapy: vox clamantis in deserto vel lux in tenebris?
    McFadden ER
    J Allergy Clin Immunol; 1995 Mar; 95(3):641-51. PubMed ID: 7897145
    [No Abstract]   [Full Text] [Related]  

  • 55. Beta 2-agonists and New Zealand asthma mortality.
    Burgess C; Crane J; Pearce N; Beasley R
    Lancet; 1991 Apr; 337(8747):982-3. PubMed ID: 1678066
    [No Abstract]   [Full Text] [Related]  

  • 56. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
    JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three generations of ongoing controversies concerning the use of short acting beta-agonist therapy in asthma: a review.
    Jalba MS
    J Asthma; 2008; 45(1):9-18. PubMed ID: 18259990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Increased asthma fatality in chronic administration of beta agonists?].
    Geisler LS
    Dtsch Med Wochenschr; 1993 Feb; 118(6):206-7. PubMed ID: 8094666
    [No Abstract]   [Full Text] [Related]  

  • 59. [Regular use of inhaled beta-agonist and steroid in the therapy of asthma].
    Abe J
    Nihon Naika Gakkai Zasshi; 1992 Jun; 81(6):835-9. PubMed ID: 1357045
    [No Abstract]   [Full Text] [Related]  

  • 60. [The clinical usefulness of the combined use of inhaled beta 2-agonist and inhaled steroid in asthma].
    Yamamoto C; Narita N
    Nihon Rinsho; 1996 Nov; 54(11):3087-92. PubMed ID: 8950960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.